Tumour angiogenesis: an elusive target in castration-resistant prostate cancer
Lancet Oncol
.
2013 Jul;14(8):681-2.
doi: 10.1016/S1470-2045(13)70239-0.
Epub 2013 Jun 4.
Authors
Matthew D Galsky
1
,
William K Oh
Affiliation
1
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. matthew.galsky@mssm.edu
PMID:
23742876
DOI:
10.1016/S1470-2045(13)70239-0
No abstract available
Publication types
Comment
MeSH terms
Androgen Antagonists / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Male
Orchiectomy*
Prostatic Neoplasms / drug therapy*
Substances
Androgen Antagonists